`
`In re Patent of:
`
`Ross et a1.
`
`U.S. Patent No.:
`
`9,284,342
`
`Issue Date:
`March 15, 2016
`Appl. Serial No.: 13/925,078
`Filing Date:
`June 24, 2013
`Title:
`NUCLEOSIDE PHOSPHORAMIDATES
`
`Mail Stop Patent Board
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`
`PO. Box 1450
`
`Alexandria, VA 22313—1450
`
`PATENT OWNER’S POWER OF ATTORNEY IN AN INTER PARTES REVIEW
`
`Patent Owner, Gilead Pharmasset LLC, hereby appoints the following practitioners as its
`
`attorneys to transact all business in the United States Patent & Trademark Office associated with
`
`the inter partes review of the above-captioned patent:
`
`David L. Cavanaugh, Reg. No. 36,476
`Emily R. Whelan, Reg. No. 50,391
`Dorothy P. Whelan, Reg. No. 33,814
`Michael J. Kane, Reg. No. 39,722
`W. Chad Shear, Reg. No. 47,938
`
`and all practitioners associated with PTO Customer Numbers 26191 and 24395.
`
`I have the authority to execute this document on behalf of Gilead Pharmasset LLC.
`
`Gilead Pharmasset LLC
`
`
`
`Name:
`Title:
`Date:
`
`:5- EU” ”8/1?an
`19 5'».
`£4“ / «5....
`H " q —— I?—
`
`ActiveUS 165491629v. l
`
`